Nothing was detected but, to be safe, the doctor arranged a blood test which then revealed Gary had an elevated PSA (prostate ...

An expert shares crucial insights on prostate cancer, highlighting key facts and preventive measures that every man over 40 ...

Company positioned to initiate multiple Phase 1 clinical trials in 2025 for ART-101 and additional novel radiopharmaceutical assets – ...

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

The CAR-T Cell Therapy Market is growing rapidly with expanding indications, rising trials, and innovations in solid tumor and autoimmune applications.

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...